TP53 and Huntington disease: However, we hypothesize that the decrease in p53 activity that is needed to achieve reprogramming (either stochastically, or as a matter of design during the reprogramming process) selectively increases the risk of genomic instability in the presence of an HD genotype by inhibiting a potential p53-mediated hormesis effect resulting from low-level HD dependent DNA damage.